Eden Research (LON:EDEN) Reaches New 1-Year Low – Here’s Why

Eden Research plc (LON:EDEN)’s share price reached a new 52-week low during trading on Thursday . The company traded as low as GBX 2.75 ($0.04) and last traded at GBX 2.90 ($0.04), with a volume of 281615 shares. The stock had previously closed at GBX 2.93 ($0.04).

Eden Research Stock Down 0.7 %

The company has a 50 day moving average price of GBX 3.41 and a two-hundred day moving average price of GBX 3.74. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The stock has a market cap of £14.56 million, a PE ratio of -9.56 and a beta of 0.92.

Insider Transactions at Eden Research

In other Eden Research news, insider Alexander John Abrey acquired 540,540 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The shares were bought at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,985.50). Also, insider Lykele van der Broek bought 256,000 shares of the business’s stock in a transaction that occurred on Thursday, February 6th. The shares were acquired at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($13,253.95). Insiders purchased 964,487 shares of company stock worth $3,690,001 over the last three months. 14.02% of the stock is currently owned by company insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.